1. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000; 88:12 Suppl. 2961–2978.
Article
2. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005; 63:1567–1575.
Article
3. Sigua-Rodriguez EA, da Costa Ribeiro R, de Brito AC, Alvarez-Pinzon N, de Albergaria-Barbosa JR. Bisphosphonaterelated osteonecrosis of the jaw: a review of the literature. Int J Dent. 2014; 2014:192320.
Article
4. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonateassociated osteonecrosis of the jaws. Dentomaxillofac Radiol. 2006; 35:236–243.
Article
5. Kim SH, Park SJ, Oh JJ, Lee ES. A case of cutaneous sinus tract of dental origin. Ann Dermatol. 2002; 14:235–238.
Article